S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:TWST

Twist Bioscience (TWST) Stock Price, News & Analysis

$34.31
-0.17 (-0.49%)
(As of 03/28/2024 ET)
Today's Range
$34.00
$35.09
50-Day Range
$32.28
$41.50
52-Week Range
$11.46
$43.21
Volume
1.19 million shs
Average Volume
714,026 shs
Market Capitalization
$1.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.40

Twist Bioscience MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9.0% Upside
$37.40 Price Target
Short Interest
Bearish
20.77% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
0.54mentions of Twist Bioscience in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$294,282 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.17) to ($2.81) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.75 out of 5 stars

Medical Sector

703rd out of 939 stocks

Biological Products, Except Diagnostic Industry

118th out of 158 stocks

TWST stock logo

About Twist Bioscience Stock (NASDAQ:TWST)

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

TWST Stock Price History

TWST Stock News Headlines

Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
TWST Apr 2024 42.500 put
TWST Jul 2024 42.500 call
TWST Mar 2024 25.000 call
TWST Mar 2024 45.000 put
Twist Bioscience Is Poised for a Rally: How to Play It
Twist Bioscience: A 'Hold' In DNA Data Storage
Twist Bioscience Shareholders Elect Directors, Approve Compensation
Twist Bioscience: Strong Performance In A Soft Market
Twist Bioscience price target raised by $6 at JPMorgan, here's why
Twist Bioscience Corp (TWST)
Q1 2024 Twist Bioscience Corp Earnings Call
See More Headlines
Receive TWST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/02/2024
Today
3/29/2024
Next Earnings (Estimated)
5/03/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:TWST
Fax
N/A
Employees
919
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$37.40
High Stock Price Target
$45.00
Low Stock Price Target
$27.00
Potential Upside/Downside
+9.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-204,620,000.00
Pretax Margin
-77.99%

Debt

Sales & Book Value

Annual Sales
$245.11 million
Book Value
$10.86 per share

Miscellaneous

Free Float
55,552,000
Market Cap
$1.98 billion
Optionable
Optionable
Beta
1.64
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Emily Marine Leproust Ph.D. (Age 50)
    Co-Founder, Chairman & CEO
    Comp: $1.37M
  • Dr. Patrick John Finn Ph.D. (Age 52)
    President & COO
    Comp: $943.94k
  • Ms. Paula  GreenMs. Paula Green (Age 56)
    Senior Vice President of Human Resources
    Comp: $618.48k
  • Dr. William Charles Banyai Ph.D. (Age 69)
    Senior VP of Advanced Development, GM of Data Storage & Director
    Comp: $711.34k
  • Mr. Adam Laponis (Age 47)
    Chief Financial Officer
  • Mr. Robert F. Werner (Age 51)
    VP & Chief Accounting Officer
  • Mr. Siyuan Chen
    Chief Technology Officer
  • Dr. Aaron K. Sato Ph.D.
    Chief Scientific Officer
  • Mr. Chet Gandhi
    Chief Information Officer
  • Mr. Dennis Cho (Age 53)
    Senior VP, General Counsel, Secretary and Chief Ethics & Compliance Officer
    Comp: $537.93k

TWST Stock Analysis - Frequently Asked Questions

Should I buy or sell Twist Bioscience stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TWST shares.
View TWST analyst ratings
or view top-rated stocks.

What is Twist Bioscience's stock price target for 2024?

4 Wall Street research analysts have issued 1-year price objectives for Twist Bioscience's shares. Their TWST share price targets range from $27.00 to $45.00. On average, they expect the company's stock price to reach $37.40 in the next year. This suggests a possible upside of 9.0% from the stock's current price.
View analysts price targets for TWST
or view top-rated stocks among Wall Street analysts.

How have TWST shares performed in 2024?

Twist Bioscience's stock was trading at $36.86 at the start of the year. Since then, TWST stock has decreased by 6.9% and is now trading at $34.31.
View the best growth stocks for 2024 here
.

When is Twist Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 3rd 2024.
View our TWST earnings forecast
.

How were Twist Bioscience's earnings last quarter?

Twist Bioscience Co. (NASDAQ:TWST) issued its quarterly earnings results on Friday, February, 2nd. The company reported ($0.75) earnings per share for the quarter, topping analysts' consensus estimates of ($0.78) by $0.03. The business had revenue of $71.50 million for the quarter, compared to analyst estimates of $67.59 million. Twist Bioscience had a negative trailing twelve-month return on equity of 32.16% and a negative net margin of 78.44%. The company's quarterly revenue was up 31.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.74) earnings per share.

What guidance has Twist Bioscience issued on next quarter's earnings?

Twist Bioscience updated its second quarter 2024 earnings guidance on Friday, February, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $70.0 million-$71.0 million, compared to the consensus revenue estimate of $70.1 million.

What is Emily Leproust's approval rating as Twist Bioscience's CEO?

44 employees have rated Twist Bioscience Chief Executive Officer Emily Leproust on Glassdoor.com. Emily Leproust has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Twist Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Twist Bioscience investors own include CrowdStrike (CRWD), Pfizer (PFE), DocuSign (DOCU), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD), JD.com (JD), Tesla (TSLA) and Twilio (TWLO).

When did Twist Bioscience IPO?

Twist Bioscience (TWST) raised $75 million in an IPO on Wednesday, October 31st 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Cowen acted as the underwriters for the IPO and Allen & Company and Baird were co-managers.

Who are Twist Bioscience's major shareholders?

Twist Bioscience's stock is owned by many different retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (12.48%), Vanguard Group Inc. (9.47%), Vanguard Group Inc. (9.47%), Artisan Partners Limited Partnership (6.44%), Sumitomo Mitsui Trust Holdings Inc. (6.20%) and Nikko Asset Management Americas Inc. (6.20%). Insiders that own company stock include Dennis Cho, Emily M Leproust, Emily M Leproust, James M Thorburn, Jan Johannessen, John P Molloy, Keith Crandell, Mark Daniels, Nicolas Barthelemy, Patrick John Finn, Patrick Weiss, Paula Green, Robert Chess, Robert F Werner and William Banyai.
View institutional ownership trends
.

How do I buy shares of Twist Bioscience?

Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TWST) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners